elsewhere. . . . . .
Hey Whitten - with >12,000 posts and >150 followers you know the game and are a leader......you know the game far better than most ......my sense is this could easily run to 10cents plus on FDA OTC Clearance for ActiPatch in the US. A retrace to allow the company to reveal its rollout strategy and any major players for marketing and launch could rerun it. I was long a ton in 09 when it ran from .003 to 12.9 cents, didn't get the high, but sold from .08 up. Don't you hate people who say hey sold at the high,,,,every time,,,,all their lives? That run was on the basis of a pure pump about FDA approval for OTC but we knew it was early and FDA did not have the staff, knowledge or pathways established for OTC clearance.
There were 1Billion shares then + -, and there was no reason why it would not have run to >a buck then. . . . but, as I say it was too early. Now, it is real - FDA hired the staff it said it would, reclassified BIEL ActiPatch as a Class II device, established a new category called SWT from the old PEMF and here we are waiting patiently for clearance.......
Real question is would market cap be for a US company with a patented pain relief device with solid efficacy, drug-free, side-effect free, >1million in users hands, >1Billion treatment hours, OTC in 50 countries including Canada and the UK and >140Million Americans suffering from chronic and acute pain today, right now? I say, disruptive technology Tsunami . . . . . hope this helps
